GlassScriptPhysician profile
Sanjay Grover
NPI 1982776852
$33,964.23
in general payments reported to CMS, 2019-2025
25 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,866 · 2020: $634 · 2021: $893 · 2022: $1,853 · 2023: $1,299 · 2024: $10K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24K · Consulting Fee: $1,000 · Travel and Lodging: $747 · Long Term Medical Supply Or Device Loan: $652 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24,232.20 |
| Consulting Fee | $1,000.00 |
| Travel and Lodging | $747.37 |
| Long Term Medical Supply Or Device Loan | $651.60 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $12,500.00 | 2025 | M22 |
| Revance Therapeutics, INC. | $7,447.22 | 2024-2025 | Daxxify |
| Allergan, INC. | $3,585.85 | 2019-2022 | |
| Mentor Worldwide LLC | $3,428.72 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Siltex Round Spectrum |
| Motiva USA, LLC | $2,686.79 | 2024-2025 | |
| Sientra, INC. | $882.72 | 2019-2022 | |
| Integra Lifesciences Corporation | $732.99 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Abbvie INC. | $550.52 | 2023-2025 | |
| Merz North America, INC. | $374.30 | 2021-2022 | |
| Galderma Laboratories, L.P. | $237.10 | 2019-2024 | |
| Apyx Medical Corporation | $227.33 | 2019-2020 | |
| Davol INC. | $202.17 | 2022 | |
| Tela Bio, INC. | $190.41 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acera Surgical, INC. | $148.38 | 2024 | Restrata Wound Matrix |
| Kerecis Limited | $144.64 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $131.04 | 2022 | |
| Organogenesis INC. | $122.26 | 2024 | Puraply Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $115.18 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $93.25 | 2021 | |
| Tepha INC | $57.41 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $45.10 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $16.37 | 2021 | |
| Avanos Medical | $16.36 | 2019 | |
| Smith+Nephew, INC. | $15.71 | 2021 | |
| Baxter Healthcare | $12.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Grover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.